DUBLIN, Oct. 27, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/vdnmk4/neurovascular) has announced the addition of the "Neurovascular Devices/Interventional Neurology Market by Technology (Embolization, Carotid Stenting, Balloon Angioplasty, Neurothrombectomy), Product - Global Forecast to 2020 " report to their offering.
The global interventional neurology market is poised to reach $2,370.4 Million by 2020, growing at a CAGR of 8.4% from 2015 to 2020
Market growth can be attributed to factors such as growing target patient population, technological advancements in the field of interventional neurosurgeries, favorable medical reimbursements across mature markets, and expansion in healthcare infrastructure across developing countries. However, ongoing healthcare reforms in the U.S. and a dearth of skilled neurosurgeons are restraining the growth of this market. In addition, stringent regulatory policies (that regulate product development and commercialization) across major markets are posing significant challenges for market growth.
On the basis of product, the neurovascular devices market is classified into four major segmentsaneurysm coiling & embolization devices (includes embolic coils, flow diversion devices, and liquid embolic agents), cerebral balloon angioplasty & stenting systems (includes carotid artery stents and embolic protection systems), support devices (includes microcatheters and microguidewires), and neurothrombectomy devices (includes clot retrievers, suction & aspiration devices, and snares). The aneurysm coiling and embolization devices segment is expected to account for the largest share of 58.8% of the global neurovascular devices market, by product, in 2015. Its large share is augmented by factors such as the significant demand for bare embolic coils among neurosurgeons for brain aneurysm treatment, increasing R&D to develop & commercialize novel flow diverters, and low procedural costs associated with neurovascular embolization.
On the basis of technology, the neurovascular devices market is classified into four segments embolization & coiling, carotid artery angioplasty & stenting, supporting techniques, and neurothrombectomy. The embolization & coiling segment is expected to account for the largest market share in 2015, while the carotid artery angioplasty & stenting segment is poised to be the fastest-growing segment in the next five years. Its high growth can be attributed to the growing adoption of carotid stents and balloon catheters among neurosurgeons; expansion in patient population suffering from atherosclerosis and ischemic strokes; increasing number of interventional neurologists, neurosurgical centers, and hospitals; and improving reimbursement scenario across developed markets.
Stryker Corporation (U.S.), Medtronic, plc (U.S.), Johnson & Johnson (U.S.), Terumo Corporation (Japan), Penumbra, Inc. (U.S.), Abbott Laboratories (U.S.), Merit Medical Systems, Inc. (U.S.), W. L. Gore & Associates, Inc. (U.S.), Microport Scientific Corporation (China), and Medikit Co., Ltd. (Japan) are the key players operating in the global neurovascular devices market.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Neurovascular Devices/Interventional Neurology Market
7 Neurovascular Devices/Interventional Neurology Market
8 Neurovascular Devices/Interventional Neurology Market
9 Competitive Landscape
10 Company Profiles
- Abbott Laboratories
- Geographic Mix
- Johnson & Johnson
- Medikit Co., Ltd.
- Medtronic Plc
- Merit Medical Systems, Inc.
- Microport Scientific Corporation
- Penumbra, Inc.
- Strategic Benchmarking
- Stryker Corporation
- Terumo Corporation
- W. L. Gore & Associates, Inc.
For more information visit
Laura Wood, +353-1-481-1716, firstname.lastname@example.org
SOURCE Research and Markets